These findings support the existence of positive feedback of ERK pathway in TGFBRII-edited DNM cells and provide a novel combined targeting of both TGF-β and ERK signaling pathways in advance prostate cancer. The gene discussed is TGFB1; the disease is Familial prostate cancer.